Wijnand van den Boom1, Roos Konings1, Udi Davidovich1, Theo Sandfort2, Maria Prins1,3, Ineke G Stolte1. 1. Public Health Service Amsterdam, Cluster Infectious Diseases, Department of Research, Amsterdam, Netherlands. 2. HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY, USA. 3. Department of Infectious Diseases, Tropical Medicine and AIDS, CINIMA, Academic Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: We investigated the prevalence and protective value of serosorting [ie, establishing HIV concordance in advance to practice unprotected anal intercourse (UAI)] with casual partners (CP) among HIV-negative men who have sex with men (MSM) using longitudinal data from 2007 to 2011. METHODS: Men of the Amsterdam Cohort Studies were tested biannually for HIV-1 antibodies and filled in questionnaires about sexual behavior in the preceding 6 months. HIV incidence was examined among men who practiced UAI, UAI with serosorting, or consistent condom use, using Poisson regression. RESULTS: Of 445 MSM with CPs, 31 seroconverted for HIV during a total follow-up of 1107 person-years. Overall observed HIV incidence rate was 2.8/100 person-years. Consistent condom use was reported in 64%, UAI in 25%, and UAI with serosorting in 11% of the 2137 follow-up visits. MSM who practiced serosorting were less likely to seroconvert [adjusted incidence rate ratio (aIRR) = 0.46; 95% confidence interval (CI): 0.13 to 1.59] than MSM who had UAI, but more likely to seroconvert than MSM who consistently used condoms (aIRR = 1.32; 95% CI: 0.37 to 4.62), although differences in both directions were not statistically significant. MSM who consistently used condoms were less likely to seroconvert than MSM who had UAI (aIRR = 0.37; 95% CI: 0.18 to 0.77). DISCUSSION: The protective effect for serosorting we found was not statistically significant. Consistent condom use was found to be most protective against HIV infection. Larger studies are needed to demonstrate whether serosorting with CPs offers sufficient protection against HIV infection, and if not, why it fails to do so.
BACKGROUND: We investigated the prevalence and protective value of serosorting [ie, establishing HIV concordance in advance to practice unprotected anal intercourse (UAI)] with casual partners (CP) among HIV-negative men who have sex with men (MSM) using longitudinal data from 2007 to 2011. METHODS:Men of the Amsterdam Cohort Studies were tested biannually for HIV-1 antibodies and filled in questionnaires about sexual behavior in the preceding 6 months. HIV incidence was examined among men who practiced UAI, UAI with serosorting, or consistent condom use, using Poisson regression. RESULTS: Of 445 MSM with CPs, 31 seroconverted for HIV during a total follow-up of 1107 person-years. Overall observed HIV incidence rate was 2.8/100 person-years. Consistent condom use was reported in 64%, UAI in 25%, and UAI with serosorting in 11% of the 2137 follow-up visits. MSM who practiced serosorting were less likely to seroconvert [adjusted incidence rate ratio (aIRR) = 0.46; 95% confidence interval (CI): 0.13 to 1.59] than MSM who had UAI, but more likely to seroconvert than MSM who consistently used condoms (aIRR = 1.32; 95% CI: 0.37 to 4.62), although differences in both directions were not statistically significant. MSM who consistently used condoms were less likely to seroconvert than MSM who had UAI (aIRR = 0.37; 95% CI: 0.18 to 0.77). DISCUSSION: The protective effect for serosorting we found was not statistically significant. Consistent condom use was found to be most protective against HIV infection. Larger studies are needed to demonstrate whether serosorting with CPs offers sufficient protection against HIV infection, and if not, why it fails to do so.
Authors: Limin Mao; June M Crawford; Harm J Hospers; Garrett P Prestage; Andrew E Grulich; John M Kaldor; Susan C Kippax Journal: AIDS Date: 2006-05-12 Impact factor: 4.177
Authors: Sarahmona M Przybyla; Carol E Golin; Laura Widman; Catherine A Grodensky; Jo Anne Earp; Chirayath Suchindran Journal: AIDS Care Date: 2012-09-28
Authors: Fengyi Jin; June Crawford; Garrett P Prestage; Iryna Zablotska; John Imrie; Susan C Kippax; John M Kaldor; Andrew E Grulich Journal: AIDS Date: 2009-01-14 Impact factor: 4.177
Authors: Iryna B Zablotska; John Imrie; Garrett Prestage; June Crawford; Patrick Rawstorne; Andrew Grulich; Fengyi Jin; Susan Kippax Journal: AIDS Care Date: 2009-04
Authors: Nicole Crepaz; Gary Marks; Adrian Liau; Mary M Mullins; Latrina W Aupont; Khiya J Marshall; Elizabeth D Jacobs; Richard J Wolitski Journal: AIDS Date: 2009-08-24 Impact factor: 4.177
Authors: Leo Wilton; Beryl Koblin; Vijay Nandi; Guozhen Xu; Carl Latkin; David Seal; Stephen A Flores; Pilgrim Spikes Journal: AIDS Behav Date: 2015-12
Authors: Christian Grov; H Jonathon Rendina; Raymond L Moody; Ana Ventuneac; Jeffrey T Parsons Journal: AIDS Patient Care STDS Date: 2015-09-08 Impact factor: 5.078
Authors: Fengyi Jin; Garrett P Prestage; Limin Mao; I Mary Poynten; David J Templeton; Andrew E Grulich; Iryna Zablotska Journal: Front Immunol Date: 2015-02-27 Impact factor: 7.561